Clinical Oncology Letters
http://www.col.periodikos.com.br/article/doi/10.4322/col.2018.007
Clinical Oncology Letters
Artigo Original

Paullinia cupana (Guarana) for Chemotherapy-Induced Fatigue in Patients with Solid Tumors: A Meta-Analysis

Paullinia cupana (Guaraná) para fadiga induzida por quimioterapia em pacientes com tumores sólidos: uma meta-análise

Cicilia Marques Rodrigues, Auro del Giglio

Downloads: 0
Views: 210

Abstract

Objective: To review the literature systematically to summarize all retrievable existent data on the anti-fatigue effects of Paullinia cupana in chemotherapy-treated patients. Methods: Between September 2017 and December 2017 in the PUBMED, MEDLINE and Cochrane Library databases for publications in English of adult human studies (19 years or older) of patients with solid tumors undergoing chemotherapy who received Paullinia cupana versus placebo for fatigue. We employed the following MeSH (Medical Subject Headings) descriptors: fatigue, guarana (Paullinia) and chemotherapy. We also searched the bibliography of the selected articles. Results: We included three randomized clinical trials involving 134 patients. Despite significant heterogeneity, as compared with placebo, Paullinia cupana produced statistically significant improvements in fatigue measured by the Chalder (p <0.00001), Facit F (p = 0.0004) and BFI (p = 0.004) questionnaires. There was no important toxicity related to the Guarana use. Conclusion: We conclude that Paullinia cupana is active for fatigue induced by chemotherapy in patients with solid tumors.

Keywords

Paullinia cupana; guarana; fatigue; chemotherapy

Resumo

Objetivo: Revisar a literatura sistematicamente para resumir todos os dados existentes recuperáveis sobre os efeitos anti-fadiga de Paullinia cupana em pacientes tratados com quimioterapia. Métodos: Entre setembro de 2017 e dezembro de 2017, procuramos, nas bases de dados PUBMED, MEDLINE e Cochrane Library. por publicações em inglês de adultos humanos (19 anos ou mais) de pacientes com tumores sólidos submetidos a quimioterapia que receberam Paullinia cupana versus placebo para fadiga. Empregamos os seguintes descritores MeSH (Medical Subject Headings): fadiga, guaraná (Paullinia) e quimioterapia. Também pesquisamos a bibliografia dos artigos selecionados. Resultados: Foram incluídos três ensaios clínicos randomizados envolvendo 134 pacientes. Apesar da heterogeneidade significativa, em comparação com o placebo, Paullinia cupana produziu melhorias estatisticamente significativas na fadiga medida pelos questionários Chalder (p <0,00001), Facit F (p = 0,0004) e BFI (p = 0,004). Não houve toxicidade importante relacionada ao uso de guaraná. Conclusão: Concluímos que a Paullinia cupana é ativa para a fadiga induzida pela quimioterapia em pacientes com tumores sólidos.

Palavras-chave

Paullinia cupana; guaraná; fadiga; quimioterapia

Referências

1. Campos MPO, Hassan BJ, Riechelmann R, Giglio A. Cancer-related fatigue: a review. Rev Assoc Med Bras. 2011;57(2):211-9. http://dx.doi.org/10.1590/S0104-42302011000200021. PMid:21537710.

2. Campos MPO, Riechelmann R, Martins LC, Hassan BJ, Casa FB, Del Giglio A. Guarana Paullinia cupana improves fatigue in Breast Cancer patients undergoing systemic chemotherapy. J Altern Complement Med. 2011;17(6):505-12. http://dx.doi.org/10.1089/acm.2010.0571. PMid:21612429.

3. Cella D, Viswanathan H, Hays R, et al. Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy. Cancer. 2008;113(6):1480-8. http://dx.doi.org/10.1002/cncr.23698. PMid:18642348.

4. Wang XS, Giralt SA, Mendoza TR, et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin’s lymphoma. J Clin Oncol. 2002;20(5):1319-28. PMid:11870175.

5. Gupta D, Lis CG, Grutsch JF. The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage. 2007;34(1):40-7. http://dx.doi.org/10.1016/j.jpainsymman.2006.10.012. PMid:17532179.

6. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12(Suppl 1):22-34. http://dx.doi.org/10.1634/theoncologist.12-S1-22. PMid:17573453.

7. Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol. 2008;26(34):5618-29. http://dx.doi.org/10.1200/JCO.2007.15.9053. PMid:18981466.

8. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008;100(16):1155-66. http://dx.doi.org/10.1093/jnci/djn250. PMid:18695134.

9. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev. 2010;(7):CD006704. PMid:20614448.

10. Bruera E, Yennurajalingam S, Palmer JL, et al. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol. 2013;31(19):2421-7. http://dx.doi.org/10.1200/JCO.2012.45.3696. PMid:23690414.

11. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013;31(25):3076-82. http://dx.doi.org/10.1200/JCO.2012.44.4661. PMid:23897970.

12. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186-96. http://dx.doi.org/10.1002/(SICI)1097-0142(19990301)85:5<1186::AIDCNCR24>3.0.CO;2-N. PMid:10091805.

13. MdAnderson. The Brief Fatigue Inventory - BFI [Internet]. Houston: The University of Texas MD Anderson Cancer Center; 1997 [cited 2019. Apr, 03]. Available from: https://www.mdanderson.org/research/departments-labsinstitutes/departments-divisions/symptom-research/symptom-assessment-tools/brief-fatigue-inventory.html

14. FACIT. Questionnaires [Internet]. FACIT.org; 2010. [cited 2019. Apr, 03]. Available from: http://www.facit.org/FACITOrg/Questionnaires

15. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a tafigue scale. J Psychosom Res. 1993;37(2):147-53. http://dx.doi.org/10.1016/0022-3999(93)90081-P. PMid:8463991.

16. Cochrane. RevMan 5 [Internet]. London: Cochrane Community; 2014 [cited 2019. Apr, 03]. Available from: http://community.cochrane.org/tools/review-production-tools/revman-5/revman-5-download

17. Higgins J, Green S. Cochrane handbook of systematic reviws of interventions 5.2 [Internet]. London: Cochrane Library; 2017 [cited 2019. Apr, 03]. Available from: http://training.cochrane.org/handbook

18. Miranda VC, Trufelli DC, Fêde ÂB, et al. Guarana (Paullinia cupana) for chemotherapy-related fatigue. Einstein. 2008;6(2):195-9.

19. Sette CVM, Alcântara BBR, Schoueri JHM, et al. Purified dry Paullinia cupana (PC-18) extract for chemotherapyinduced fatigue: results of two double-blind randomized clinical trials. J Diet Suppl. 2018;15(5):673. http://dx.doi.org/10.1080/19390211.2017.1384781. PMid:29190155.

20. McMillan R, Forssell H, Buchanan J, Glenny A, Weldon J, Zakrzewska J. Interventions for treating burning mouth syndrome. Cochrane Libr. 2016;11:CD002779. PMid:27855478.

21. Mel JR, Salar A, Rodríguez CA, et al. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia. Cochrane Database Syst Rev. 2008;24(10):2931-42. http://dx.doi.org/10.1185/03007990802381323. PMid:18775103.

22. Berger AM, Lockhart K, Agrawal S. Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens. Oncol Nurs Forum. 2009;36(5):563-70. http://dx.doi.org/10.1188/09.ONF.563-570. PMid:19726396.

23. Cavalcanti AL, Oliveira MC, Florentino V, Santos J, Vieira F, Cavalcanti C. Short communication: in vitro assessment of erosive potential of energy drinks. Eur Arch Paediatr Dent. 2010;11(5):253-5. http://dx.doi.org/10.1007/BF03262757. PMid:20932401.

24. Giglio AB, Cubero DI, Lerner TG, et al. Purified dry extract of Paullinia cupana (guaraná) (PC-18) for chemotherapyrelated fatigue in patients with solid tumors: an early discontinuation study. J Diet Suppl. 2013;10(4):325-34. http://dx.doi.org/10.3109/19390211.2013.830676. PMid:24237188.

25. Angelo PC, Nunes-Silva CG, Brígido MM, et al. Guarana (Paullinia cupana var. sorbilis), an anciently consumed stimulant from the Amazon rain forest: the seeded-fruit transcriptome. Plant Cell Rep. 2008;27(1):117-24. http://dx.doi.org/10.1007/s00299-007-0456-y. PMid:17917729.

26. Edwards HGM, Farwell DW, Oliveira LFC, Alia J-M, Hyaric ML, Ameida MV. FT-Raman spectroscopic studies of guarana and some extracts. Anal Chim Acta. 2005;532(2):177-86. http://dx.doi.org/10.1016/j.aca.2004.10.055.

27. Yoshizawa S, Horiuchi T, Fujiki H, Yoshida T, Okuda T, Sugimura T. Antitumor promoting activity of (−)‐epigallocatechin gallate, the main constituent of “Tannin” in green tea. Phytother Res. 1987;1(1):44-7. http://dx.doi.org/10.1002/ptr.2650010110.

28. Marcon R, Del Giglio A, Pianowski LF, Calixto JB. An analysis of the role of paulinia cupana (Guaraná) in blood IL-1b and brain IL-6 levels as well as brain IL-6 and TNF-a mRNA expression in mice. J Clin Oncol. 2011;29(Suppl 15):e21002. http://dx.doi.org/10.1200/jco.2011.29.15_suppl.e21002.

29. Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integr Cancer Ther. 2013;12(4):312-22. http://dx.doi.org/10.1177/1534735412464551. PMid:23142798.

30. Barton DL, Liu H, Dakhil S, et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013;105(16):1230-8. http://dx.doi.org/10.1093/jnci/djt181. PMid:23853057.

31. Su CX, Wang L, Grant S, Liu J. Chinese herbal medicine for cancer-related fatigue: a systematic review of randomizes clinical trials. Complement Ther Med. 2014;22(3):567-79. http://dx.doi.org/10.1016/j.ctim.2014.04.007. PMid:24906595.

5cdafd2b0e8825415b86c887 col Articles
Links & Downloads

Clin Onc Let

Share this page
Page Sections